Clinical trials
Phase 3 Mucopolysaccharidosis II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Green Cross Corporation | 2 |
| JCR Pharmaceuticals Co., Ltd. | 2 |
| Aldagen | 1 |
| GC Biopharma Corp | 1 |
| REGENXBIO Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mucopolysaccharidosis II | 7 |
| Sudden Infant Death | 4 |
| Adrenoleukodystrophy | 1 |
| Canavan Disease | 1 |
| Fucosidosis | 1 |
| Gangliosidosis, GM1 | 1 |
| Leukodystrophy, Globoid Cell | 1 |
| Leukodystrophy, Metachromatic | 1 |
| Lysosomal Storage Diseases | 1 |
| Metabolism, Inborn Errors | 1 |
Trials
Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.